HOBS MOAT MEDICAL CENTRE — All Prescriptions & Medications — Page 2
Practice Code: M89019 | SOLIHULL, B92 8ED
Showing results 51-100 of 572
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Diazepam | 788 | 26.6K | £573 | +58.2% ▲ |
| Dapagliflozin | 770 | 32.7K | £40.6K | -38.5% ▼ |
| Ferrous sulfate | 760 | 50.3K | £2.1K | +47.8% ▲ |
| Candesartan cilexetil | 743 | 43.9K | £1.9K | -37.4% ▼ |
| Quetiapine | 713 | 31.1K | £7.6K | +14.5% ▲ |
| Doxazosin mesilate | 697 | 47.5K | £3.4K | -34.7% ▼ |
| Ezetimibe | 692 | 35.1K | £6.2K | -2.7% ▼ |
| Isosorbide mononitrate | 681 | 35.8K | £5.5K | +3.0% ▲ |
| Latanoprost | 672 | 12.4K | £3.9K | +38.4% ▲ |
| Insulin glargine | 662 | 3,628 | £25.6K | +133.2% ▲ |
| Hydrocortisone | 662 | 17.5K | £6.4K | +47.6% ▲ |
| Doxycycline hyclate | 658 | 9,489 | £1.4K | +28.4% ▲ |
| Codeine phosphate | 635 | 54.9K | £2.0K | -11.6% ▼ |
| Fluticasone propionate (Inhalation) | 626 | 702 | £16.3K | +61.8% ▲ |
| Montelukast | 626 | 27.3K | £1.4K | -8.6% ▼ |
| Allopurinol | 624 | 46.6K | £1.1K | -39.5% ▼ |
| Rosuvastatin calcium | 615 | 31.6K | £1.6K | -31.5% ▼ |
| Carbocisteine | 607 | 111.1K | £8.5K | +13.7% ▲ |
| Insulin aspart | 598 | 3,550 | £21.5K | +57.0% ▲ |
| Duloxetine hydrochloride | 596 | 20.2K | £2.4K | -6.2% ▼ |
| Ferrous fumarate | 587 | 56.2K | £2.2K | -19.0% ▼ |
| Felodipine | 563 | 29.8K | £4.7K | -5.2% ▼ |
| Linagliptin | 559 | 25.9K | £29.2K | +36.5% ▲ |
| Bendroflumethiazide | 550 | 38.1K | £607 | -28.9% ▼ |
| Flucloxacillin sodium | 550 | 24.6K | £1.5K | +22.3% ▲ |
| Progesterone | 550 | 46.5K | £10.2K | +31.4% ▲ |
| Betamethasone valerate | 542 | 44.7K | £2.4K | +40.8% ▲ |
| Budesonide | 529 | 1,238 | £20.4K | -2.4% ▼ |
| Edoxaban | 528 | 22.7K | £37.8K | -24.6% ▼ |
| Diclofenac diethyl | 524 | 59.6K | £4.1K | +47.6% ▲ |
| Nitrofurantoin | 517 | 7,506 | £3.9K | +8.3% ▲ |
| 496 | 6,305 | £1.9K | +137.3% ▲ | |
| Empagliflozin | 494 | 21.5K | £26.7K | -21.1% ▼ |
| Gliclazide | 490 | 40.6K | £3.4K | -42.4% ▼ |
| 483 | 238.9K | £2.9K | +83.1% ▲ | |
| Escitalopram | 470 | 20.6K | £1.2K | +65.1% ▲ |
| Alendronic acid | 468 | 2,996 | £1.1K | -37.6% ▼ |
| Sumatriptan succinate | 451 | 4,364 | £5.0K | +27.4% ▲ |
| Solifenacin | 427 | 19.6K | £744 | -10.5% ▼ |
| Desogestrel | 426 | 68.8K | £2.1K | +7.5% ▲ |
| 426 | 897 | £31.8K | -21.8% ▼ | |
| Sildenafil (Erectile Dysfunction) | 416 | 3,736 | £515 | -17.5% ▼ |
| Lamotrigine | 415 | 28.0K | £9.2K | -29.7% ▼ |
| Digoxin | 414 | 16.1K | £1.2K | +9.4% ▲ |
| Spironolactone | 411 | 17.8K | £4.0K | -23.8% ▼ |
| Estradiol with progestogen | 411 | 18.1K | £14.7K | +20.6% ▲ |
| Finasteride | 408 | 20.2K | £710 | -37.7% ▼ |
| Promethazine hydrochloride | 406 | 22.2K | £2.2K | +13.6% ▲ |
| Indapamide | 399 | 20.8K | £858 | -53.7% ▼ |
| Cyanocobalamin | 381 | 32.0K | £2.7K | +7.9% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.